Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : A US National Health Care System? -- Ignore unavailable to you. Want to Upgrade?

To: Road Walker who wrote (3031)	12/3/2007 3:47:58 PM
From: TimF	Respond to of 42652

The basic research is nice, but to actually get a real benefit you have to apply it in real world drugs. Those drugs have to be developed (which cost the company money, even if the basic research is made available to them for free), and tested (a very expensive process), and marketed. That expense is justified by the possibility of high profit. The high profit comes largely from selling drugs in the US. Which is not to say that if the US controlled drug prices the way that many other countries do, there would be no new drug development but there would be less. The point is that the new drug development isn't primarily the result of socialized medicine, but is in response to profit incentives.